Differentiated metabolomic profiling reveals plasma amino acid signatures for primary glomerular disease
Amino Acids · 2024
DOI: 10.1007/s00726-024-03407-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Amino Acids, 2024. Verfasst von Jiao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of geriatric endocrinology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China. Hauptthemen laut MEDLINE: Amino Acids, Metabolomics, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Medical Science and Technology Research Program Joint Construction Project, Henan Medical Science and Technique Foundation.
Abstract (Originalsprache)
Primary glomerular disease (PGD) is an idiopathic cause of renal glomerular lesions that is characterized by proteinuria or hematuria and is the leading cause of chronic kidney disease (CKD). The identification of circulating biomarkers for the diagnosis of PGD requires a thorough understanding of the metabolic defects involved. In this study, ultra-high performance liquid chromatography–tandem mass spectrometry was performed to characterize the amino acid (AA) profiles of patients with pathologically diagnosed PGD, including minimal change disease (MCD), focal segmental glomerular sclerosis (FSGS), membranous nephropathy, and immunoglobulin A nephropathy. The plasma concentrations of asparagine and ornithine were low, and that of aspartic acid was high, in patients with all the pathologic types of PGD, compared to healthy controls. Two distinct diagnostic models were generated using the differential plasma AA profiles using logistic regression and receiver operating characteristic analyses, with areas under the curves of 1.000 and accuracies up to 100.0% in patients with MCD and FSGS. In conclusion, the progression of PGD is associated with alterations in AA profiles, The present findings provide a theoretical basis for the use of AAs as a non-invasive, real-time, rapid, and simple biomarker for the diagnosis of various pathologic types of PGD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of geriatric endocrinology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China.
- Research Institute of Nephrology, Zhengzhou University, Zhengzhou, 450052, P. R. China.
- Henan Province Research Center For Kidney Disease, Zhengzhou, 450052, P. R. China.
- Blood Purification Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China.
- Department of endocrinology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China.
- Research Institute of Nephrology, Zhengzhou University, Zhengzhou, 450052, P. R. China. aquamarine61@163.com.
Förderung
- Henan Medical Science and Technology Research Program Joint Construction Project
- Henan Medical Science and Technique Foundation
Zitieren
APA
Wang, J., Zhou, C., Lu, L., Wang, S., Zhang, Q., & Liu, Z. (2024). Differentiated metabolomic profiling reveals plasma amino acid signatures for primary glomerular disease. Amino Acids. https://doi.org/10.1007/s00726-024-03407-4
Vancouver
Wang J, Zhou C, Lu L, Wang S, Zhang Q, Liu Z. Differentiated metabolomic profiling reveals plasma amino acid signatures for primary glomerular disease. Amino Acids. 2024. doi:10.1007/s00726-024-03407-4
BibTeX
@article{Wang2024,
author = {Wang, Jiao and Zhou, Chunyu and Lu, Liqian and Wang, Shoujun and Zhang, Qing and Liu, Zhangsuo},
title = {Differentiated metabolomic profiling reveals plasma amino acid signatures for primary glomerular disease},
journal = {Amino Acids},
year = {2024},
doi = {10.1007/s00726-024-03407-4}
}
EUVIMED